Literature DB >> 7758882

Changes of lipolytic enzymes cluster with insulin resistance syndrome. Botnia Study Group.

P Knudsen1, J Eriksson, S Lahdenperä, J Kahri, L Groop, M R Taskinen.   

Abstract

The activities of hepatic and lipoprotein lipase and the levels of lipo- and apoproteins were compared in two groups of normoglycaemic men representing the highest (n = 18) and lowest (n = 15) fasting insulin quintiles of first degree male relatives of non-insulin-dependent diabetic patients. The high insulin group representing insulin-resistant individuals had significantly lower post-heparin plasma lipoprotein lipase activity than the low insulin group (14.2 +/- 4.0 vs 20 +/- 5.8 mumol NEFA.ml-1.h-1, p < 0.001); hepatic lipase activity did not differ between the two groups (24.2 +/- 11 vs 18.0 +/- 5.3 mumol NEFA.ml-1.h-1, NS). The lipoprotein lipase/hepatic lipase ratio in the high insulin group was decreased by 66% as compared to the low insulin group (0.75 +/- 0.57 vs 1.25 +/- 0.65, p < 0.01). In the high insulin group both total and VLDL triglycerides were higher than in the low insulin group (1.61 +/- 0.57 vs 0.86 +/- 0.26 mmol/l, p < 0.001 and 1.00 +/- 0.47 vs 0.36 +/- 0.16 mmol/l, p < 0.001, respectively) whereas HDL cholesterol and HDL2 cholesterol were lower (1.20 +/- 0.30 vs 1.43 +/- 0.22 mmol/l, p < 0.05 and 0.49 +/- 0.21 vs 0.71 +/- 0.17 mmol/l, p < 0.05, respectively). Total cholesterol, LDL cholesterol or HDL3 cholesterol did not differ between the two groups. The mean particle size of LDL was smaller in the high insulin group than in the low insulin group (258 +/- 7 vs 265 +/- 6 A, p < 0.05).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7758882     DOI: 10.1007/BF00400640

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  55 in total

1.  Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk.

Authors:  M A Austin; M C King; K M Vranizan; R M Krauss
Journal:  Circulation       Date:  1990-08       Impact factor: 29.690

2.  Early abnormalities in coronary heart disease risk factors in relatives of subjects with non-insulin-dependent diabetes.

Authors:  H Sarlund; K Pyörälä; I Penttilä; M Laakso
Journal:  Arterioscler Thromb       Date:  1992-06

3.  Differential electroimmunoassay of human LpA-I lipoprotein particles on ready-to-use plates.

Authors:  H J Parra; H Mezdour; N Ghalim; J M Bard; J C Fruchart
Journal:  Clin Chem       Date:  1990-08       Impact factor: 8.327

Review 4.  Diabetes mellitus. Report of a WHO Study Group.

Authors: 
Journal:  World Health Organ Tech Rep Ser       Date:  1985

5.  Interrelationships among insulin's antilipolytic and glucoregulatory effects and plasma triglycerides in nondiabetic and diabetic patients with endogenous hypertriglyceridemia.

Authors:  H Yki-Järvinen; M R Taskinen
Journal:  Diabetes       Date:  1988-09       Impact factor: 9.461

6.  Insulin resistance and hypertriglyceridemia in nondiabetic relatives of patients with noninsulin-dependent diabetes mellitus.

Authors:  A Laws; M L Stefanick; G M Reaven
Journal:  J Clin Endocrinol Metab       Date:  1989-08       Impact factor: 5.958

Review 7.  In vivo regulation of lipolysis in humans.

Authors:  S W Coppack; M D Jensen; J M Miles
Journal:  J Lipid Res       Date:  1994-02       Impact factor: 5.922

8.  Heterozygous lipoprotein lipase deficiency due to a missense mutation as the cause of impaired triglyceride tolerance with multiple lipoprotein abnormalities.

Authors:  G Miesenböck; B Hölzl; B Föger; E Brandstätter; B Paulweber; F Sandhofer; J R Patsch
Journal:  J Clin Invest       Date:  1993-02       Impact factor: 14.808

9.  Significance of hepatic triglyceride lipase activity in the regulation of serum high density lipoproteins in type II diabetes mellitus.

Authors:  S E Kasim; K Tseng; K L Jen; S Khilnani
Journal:  J Clin Endocrinol Metab       Date:  1987-07       Impact factor: 5.958

10.  Plasma insulin and lipoprotein concentrations: an atherogenic association?

Authors:  T J Orchard; D J Becker; M Bates; L H Kuller; A L Drash
Journal:  Am J Epidemiol       Date:  1983-09       Impact factor: 4.897

View more
  9 in total

1.  Effects of mitiglinide on glucose-induced insulin release into the portal vein and fat-induced triglyceride elevation in prediabetic and diabetic OLETF rats.

Authors:  Y Mori; K Ojima; Y Fuujimori; Y Fujimori; I Aoyagi; H Kusama; Y Yamazaki; M Kojima; S Kojima; N Shibata; Y Itoh; N Tajima
Journal:  Endocrine       Date:  2006-04       Impact factor: 3.633

Review 2.  Interethnic Differences in Serum Lipids and Implications for Cardiometabolic Disease Risk in African Ancestry Populations.

Authors:  Amy R Bentley; Charles N Rotimi
Journal:  Glob Heart       Date:  2017-05-17

Review 3.  Occlusive vascular diseases in oral contraceptive users. Epidemiology, pathology and mechanisms.

Authors:  I F Godsland; U Winkler; O Lidegaard; D Crook
Journal:  Drugs       Date:  2000-10       Impact factor: 9.546

Review 4.  The role of hypertriglyceridemia in atherosclerosis.

Authors:  Ngoc-Anh Le; Mary F Walter
Journal:  Curr Atheroscler Rep       Date:  2007-08       Impact factor: 5.113

5.  Impaired fasting glucose and impaired glucose tolerance have distinct lipoprotein and apolipoprotein changes: the insulin resistance atherosclerosis study.

Authors:  Carlos Lorenzo; Sara Hartnett; Anthony J Hanley; Marian J Rewers; Lynne E Wagenknecht; Andrew J Karter; Steven M Haffner
Journal:  J Clin Endocrinol Metab       Date:  2013-02-28       Impact factor: 5.958

6.  Insulin resistance and abnormal albumin excretion in non-diabetic first-degree relatives of patients with NIDDM.

Authors:  C M Forsblom; J G Eriksson; A V Ekstrand; A M Teppo; M R Taskinen; L C Groop
Journal:  Diabetologia       Date:  1995-03       Impact factor: 10.122

7.  Body mass index and glycemic control influence lipoproteins in children with type 1 diabetes.

Authors:  Shalini Vaid; Lynae Hanks; Russell Griffin; Ambika P Ashraf
Journal:  J Clin Lipidol       Date:  2016-08-06       Impact factor: 4.766

8.  Impact of metabolic syndrome risk factors in first-degree relatives of type 2 diabetic patients.

Authors:  Susana Siewert; Sergio Filipuzzi; Leticia Codazzi; Irma Gonzalez; Marta S Ojeda
Journal:  Rev Diabet Stud       Date:  2007-11-10

9.  High-density lipoprotein subclass and particle size in coronary heart disease patients with or without diabetes.

Authors:  Li Tian; Shiyin Long; Chuanwei Li; Yinghui Liu; Yucheng Chen; Zhi Zeng; Mingde Fu
Journal:  Lipids Health Dis       Date:  2012-05-15       Impact factor: 3.876

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.